For: | Sung H, Kim SW, Hong M, Suk KT. Microbiota-based treatments in alcoholic liver disease. World J Gastroenterol 2016; 22(29): 6673-6682 [PMID: 27547010 DOI: 10.3748/wjg.v22.i29.6673] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i29/6673.htm |
Number | Citing Articles |
1 |
Alicia Rodriguez-Gonzalez, Laura Orio. Microbiota and Alcohol Use Disorder: Are Psychobiotics a Novel Therapeutic Strategy?. Current Pharmaceutical Design 2020; 26(20): 2426 doi: 10.2174/1381612826666200122153541
|
2 |
Fabio CAPUTO, Francesco PENITENTI, Barbara BERGONZONI, Lisa LUNGARO, Anna COSTANZINI, Giacomo CAIO, Roberto DE GIORGIO, Maria R. AMBROSIO, Giorgio ZOLI, Gianni TESTINO. Alcohol use disorders and liver fibrosis: an update. Minerva Medica 2024; 115(3) doi: 10.23736/S0026-4806.24.09203-6
|
3 |
Saman Khalesi, David Wayne Johnson, Katrin Campbell, Susan Williams, Andrew Fenning, Sonia Saluja, Christopher Irwin. Effect of probiotics and synbiotics consumption on serum concentrations of liver function test enzymes: a systematic review and meta-analysis. European Journal of Nutrition 2018; 57(6): 2037 doi: 10.1007/s00394-017-1568-y
|
4 |
Xia Li, Yushan Wang, Jun Zhang, Guijiao Lu, Ying You, Yu Wang, Haiyue Sun, Bo Nan, Yuhua Wang.
The effect of
Lactobacillus rhamnosus
B10
on alcoholic liver injury and intestinal microbiota in alcohol‐induced mice model
. Journal of Food Biochemistry 2022; 46(10) doi: 10.1111/jfbc.14372
|
5 |
Na Young Lee, Sang Jun Yoon, Dae Hee Han, Haripriya Gupta, Gi Soo Youn, Min Jea Shin, Young Lim Ham, Min Jung Kwak, Byung Yong Kim, Jeong Seok Yu, Do Yup Lee, Tae-Sik Park, Si-Hyun Park, Byoung Kook Kim, Hyun Chae Joung, In Suk Choi, Ji Taek Hong, Dong Joon Kim, Sang Hak Han, Ki Tae Suk. LactobacillusandPediococcusameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome. Gut Microbes 2020; 11(4): 882 doi: 10.1080/19490976.2020.1712984
|
6 |
Xiaoli Yang, Fang He, Yanting Zhang, Jing Xue, Ke Li, Xiaoxia Zhang, Lili Zhu, Zhen Wang, Hao Wang, Shaoqi Yang. Inulin Ameliorates Alcoholic Liver Disease via Suppressing LPS‐TLR4‐Mψ Axis and Modulating Gut Microbiota in Mice. Alcoholism: Clinical and Experimental Research 2019; 43(3): 411 doi: 10.1111/acer.13950
|
7 |
Binxin Cui, Lin Lin, Bangmao Wang, Wentian Liu, Chao Sun. Therapeutic potential of Saccharomyces boulardii in liver diseases: from passive bystander to protective performer?. Pharmacological Research 2022; 175: 106022 doi: 10.1016/j.phrs.2021.106022
|
8 |
Rachel M. Golonka, Matam Vijay-Kumar. Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149: 171 doi: 10.1016/bs.acr.2020.10.004
|
9 |
Lingzhi Liu, Zhikun Zhao, Huanhuan Liu, Xiaodong Xia, Chunqing Ai, Shuang Song, Chunhong Yan. Haematococcus pluvialis polysaccharides improve microbiota-driven gut epithelial and vascular barrier and prevent alcoholic steatohepatitis development. International Journal of Biological Macromolecules 2024; 274: 133014 doi: 10.1016/j.ijbiomac.2024.133014
|
10 |
Jiadi Wu, Daqiang Wu, Kelong Ma, Tianming Wang, Gaoxiang Shi, Jing Shao, Changzhong Wang, Guiming Yan. Paeonol ameliorates murine alcohol liver disease via mycobiota-mediated Dectin-1/IL-1β signaling pathway. Journal of Leukocyte Biology 2020; 108(1): 199 doi: 10.1002/JLB.3MA0120-325RR
|
11 |
Carla B. P. Silva, Jefferson Elias-Oliveira, Cameron G. McCarthy, Camilla F. Wenceslau, Daniela Carlos, Rita C. Tostes. Ethanol: striking the cardiovascular system by harming the gut microbiota. American Journal of Physiology-Heart and Circulatory Physiology 2021; 321(2): H275 doi: 10.1152/ajpheart.00225.2021
|
12 |
Ki Tae Suk, Hong Koh. New perspective on fecal microbiota transplantation in liver diseases. Journal of Gastroenterology and Hepatology 2022; 37(1): 24 doi: 10.1111/jgh.15729
|
13 |
Shi-Qin Li, Yue Shen, Jun Zhang, Cheng-Zhao Weng, Sheng-Di Wu, Wei Jiang. Immune modulation of gut microbiota and its metabolites in chronic hepatitis B. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1285556
|
14 |
Lauren Poole, Christine Dolin, Gavin Arteel. Organ–Organ Crosstalk and Alcoholic Liver Disease. Biomolecules 2017; 7(3): 62 doi: 10.3390/biom7030062
|
15 |
Yang Liu, Xin Zhang, Shuo Chen, Jiazhong Wang, Shuo Yu, Yiming Li, Meng Xu, Harouna Aboubacar, Junhui Li, Tao Shan, Jixin Wang, Gang Cao. Gut-derived lipopolysaccharide promotes alcoholic hepatosteatosis and subsequent hepatocellular carcinoma by stimulating neutrophil extracellular traps through toll-like receptor 4. Clinical and Molecular Hepatology 2022; 28(3): 522 doi: 10.3350/cmh.2022.0039
|
16 |
Cyriac Abby Philips, Juan Pablo Arab, Xingshun Qi, Norihiro Imai, Philip Augustine. Human Microbiome. 2022; : 129 doi: 10.1007/978-981-16-7672-7_6
|
17 |
Huping Huang, Zhihui Lin, Yanling Zeng, Xueyan Lin, Yali Zhang. Probiotic and glutamine treatments attenuate alcoholic liver disease in a rat model. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.8123
|
18 |
Liliana F. Iannucci, Jingfeng Sun, Brijesh K. Singh, Jin Zhou, Vincent A. Kaddai, Antonia Lanni, Paul M. Yen, Rohit A. Sinha. Short chain fatty acids induce UCP2-mediated autophagy in hepatic cells. Biochemical and Biophysical Research Communications 2016; 480(3): 461 doi: 10.1016/j.bbrc.2016.10.072
|
19 |
Zhen Wang, Xiaoxia Zhang, Lili Zhu, Xiaoli Yang, Fang He, Ting Wang, Ting Bao, Haixia Lu, Hao Wang, Shaoqi Yang. Inulin alleviates inflammation of alcoholic liver disease via SCFAs-inducing suppression of M1 and facilitation of M2 macrophages in mice. International Immunopharmacology 2020; 78: 106062 doi: 10.1016/j.intimp.2019.106062
|
20 |
Bang-Yan Li, Hang-Yu Li, Dan-Dan Zhou, Si-Yu Huang, Min Luo, Ren-You Gan, Qian-Qian Mao, Adila Saimaiti, Ao Shang, Hua-Bin Li, German Gil. Effects of Different Green Tea Extracts on Chronic Alcohol Induced‐Fatty Liver Disease by Ameliorating Oxidative Stress and Inflammation in Mice. Oxidative Medicine and Cellular Longevity 2021; 2021(1) doi: 10.1155/2021/5188205
|
21 |
Wan Wang, Xu Zhao, Yue Ma, Jing Zhang, Cong Xu, Jiage Ma, Muhammad Altaf Hussain, Juncai Hou, Shanshan Qian. Alleviating Effect of Lacticaseibacillus rhamnosus 1.0320 Combined with Dihydromyricetin on Acute Alcohol Exposure-Induced Hepatic Impairment: Based on Short-Chain Fatty Acids and Adenosine 5′-Monophosphate-Activated Protein Kinase-Mediated Lipid Metabolism Signaling Pathway. Journal of Agricultural and Food Chemistry 2023; 71(12): 4837 doi: 10.1021/acs.jafc.2c08523
|
22 |
Haripriya Gupta, Ki Tae Suk, Dong Joon Kim. Gut Microbiota at the Intersection of Alcohol, Brain, and the Liver. Journal of Clinical Medicine 2021; 10(3): 541 doi: 10.3390/jcm10030541
|
23 |
Ki Tae Suk. Liver Fibrosis and Rifaximin. The Korean Journal of Gastroenterology 2017; 70(5): 215 doi: 10.4166/kjg.2017.70.5.215
|
24 |
Tao Yang, Qijie Guan, Jin-Song Shi, Zheng-Hong Xu, Yan Geng. Metformin alleviates liver fibrosis in mice by enriching Lactobacillus sp. MF-1 in the gut microbiota. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2023; 1869(5): 166664 doi: 10.1016/j.bbadis.2023.166664
|
25 |
Giuseppe Corano Scheri, Saeid Najafi Fard, Ivan Schietroma, Andrea Mastrangelo, Claudia Pinacchio, Noemi Giustini, Sara Serafino, Gabriella De Girolamo, Eugenio Nelson Cavallari, Maura Statzu, Luca Laghi, Annamaria Vullo, Giancarlo Ceccarelli, Vincenzo Vullo, Gabriella d’Ettorre. Modulation of Tryptophan/Serotonin Pathway by Probiotic Supplementation in Human Immunodeficiency Virus–Positive Patients: Preliminary Results of a New Study Approach. International Journal of Tryptophan Research 2017; 10: 117864691771066 doi: 10.1177/1178646917710668
|
26 |
Haripriya Gupta, Gi Soo Youn, Min Jea Shin, Ki Tae Suk. Role of Gut Microbiota in Hepatocarcinogenesis. Microorganisms 2019; 7(5): 121 doi: 10.3390/microorganisms7050121
|
27 |
Linda Liang, Clarissa Saunders, Nerses Sanossian. Food, gut barrier dysfunction, and related diseases: A new target for future individualized disease prevention and management. Food Science & Nutrition 2023; 11(4): 1671 doi: 10.1002/fsn3.3229
|
28 |
Meegun Hong, Dae Hee Han, Jitaek Hong, Dong Joon Kim, Ki Tae Suk. Are Probiotics Effective in Targeting Alcoholic Liver Diseases?. Probiotics and Antimicrobial Proteins 2019; 11(2): 335 doi: 10.1007/s12602-018-9419-6
|
29 |
Eun Kyung Kwon, Geum-Dan Kang, Won-Kyeong Kim, Myung Joo Han, Dong-Hyun Kim. Lactobacillus plantarum LC27 and Bifidobacterium longum LC67 simultaneously alleviate ethanol-induced gastritis and hepatic injury in mice. Journal of Functional Foods 2017; 38: 389 doi: 10.1016/j.jff.2017.09.036
|
30 |
Hong-Wei YI, Xiao-Xiao ZHU, Xiao-Li HUANG, Yu-Zhu LAI, Yue TANG. Selenium-enriched Bifidobacterium longum protected alcohol and high fat diet induced hepatic injury in mice. Chinese Journal of Natural Medicines 2020; 18(3): 169 doi: 10.1016/S1875-5364(20)30018-2
|
31 |
Chang Liu, Yu‐Li Wang, Yong‐Yu Yang, Ning‐Ping Zhang, Chen Niu, Xi‐Zhong Shen, Jian Wu. Novel approaches to intervene gut microbiota in the treatment of chronic liver diseases. The FASEB Journal 2021; 35(10) doi: 10.1096/fj.202100939R
|
32 |
Yuan Li, Wen‐Xing Ding. Does Genetic Loss of Immunoglobulin A Have No Impact on Alcoholic Liver Disease?. Alcoholism: Clinical and Experimental Research 2017; 41(1): 20 doi: 10.1111/acer.13270
|
33 |
Shunsuke Shiba, Nobuhiro Nakamoto, Po-Sung Chu, Keisuke Ojiro, Nobuhito Taniki, Akihiro Yamaguchi, Rei Morikawa, Tadashi Katayama, Aya Yoshida, Ryo Aoki, Toshiaki Teratani, Takahiro Suzuki, Takeshi Miyamoto, Sachiko Hara, Akira Yokoyama, Takanori Kanai. Acetaldehyde exposure underlies functional defects in monocytes induced by excessive alcohol consumption. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-93086-y
|
34 |
David A. Wiss. The Assessment and Treatment of Addiction. 2019; : 21 doi: 10.1016/B978-0-323-54856-4.00002-X
|
35 |
Kalpesh G. Patel, Nikolaos T. Pyrsopoulos. Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications. 2019; : 271 doi: 10.1016/B978-0-12-815249-2.00028-2
|
36 |
Ting Wang, Zhe Wang, Zhipeng Yang, Xin Cui, Liang Yan, Zhenshang Xu, Xinli Liu. Effect of the Fermentation Broth of the Mixture of Pueraria lobata, Lonicera japonica, and Crataegus pinnatifida by Lactobacillus rhamnosus 217-1 on Liver Health and Intestinal Flora in Mice With Alcoholic Liver Disease Induced by Liquor. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.722171
|
37 |
Murali R Kuracha, Peter Thomas, Martin Tobi, Benita L McVicker. Role of cell-free network communication in alcohol-associated disorders and liver metastasis. World Journal of Gastroenterology 2021; 27(41): 7080-7099 doi: 10.3748/wjg.v27.i41.7080
|
38 |
Yonglang Cheng, Xin Xiang, Chen Liu, Tianying Cai, Tongxi Li, Yifan Chen, Junjie Bai, Hao Shi, Tianxiang Zheng, Meizhou Huang, Wenguang Fu. Transcriptomic Analysis Reveals Lactobacillus reuteri Alleviating Alcohol-Induced Liver Injury in Mice by Enhancing the Farnesoid X Receptor Signaling Pathway. Journal of Agricultural and Food Chemistry 2022; 70(39): 12550 doi: 10.1021/acs.jafc.2c05591
|
39 |
Liuying Chen, Yixin Zhu, Xiaohua Hou, Ling Yang, Huikuan Chu. The Role of Gut Bacteria and Fungi in Alcohol-Associated Liver Disease. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.840752
|
40 |
Claire Joly Condette, Bertin Elion Dzon, Farida Hamdad, Maurice Biendo, Véronique Bach, Hafida Khorsi-Cauet. Use of molecular typing to investigate bacterial translocation from the intestinal tract of chlorpyrifos-exposed rats. Gut Pathogens 2016; 8(1) doi: 10.1186/s13099-016-0129-x
|
41 |
Won-Gyeong Kim, Hye In Kim, Eun Kyung Kwon, Myung Joo Han, Dong-Hyun Kim. Lactobacillus plantarum LC27 and Bifidobacterium longum LC67 mitigate alcoholic steatosis in mice by inhibiting LPS-mediated NF-κB activation through restoration of the disturbed gut microbiota. Food & Function 2018; 9(8): 4255 doi: 10.1039/C8FO00252E
|